期刊文献+

结核分枝杆菌潜伏感染诊断方法的新进展 被引量:25

New Progress in Diagnosis of Latent Tuberculosis Infection
下载PDF
导出
摘要 每年有超过8百万人感染结核,其中绝大部分没有发展为活动性结核病,而是表现为潜伏性结核感染。大多数活动性结核病是潜伏感染的结核杆菌重新被激活所致,因此结核潜伏感染者成为结核患者的重要来源。及早诊断和治疗结核潜伏感染者是控制结核传播的最有效手段之一。我们较要综述了目前国内外结核潜伏感染的诊断方法及其新进展。 Mycobacterium tuberculosis is estimated to infect more than 8 million people annually,the majority of whom do not develop clinical tuberculosis but instead maintain the infection in a latent stage.Targeted testing and treatment of individuals with latent tuberculosis infection at increased risk of progression to active disease is a key element of tuberculosis control.This review summarized the new progress in diagnosis of latent tuberculosis infection.
作者 彭超 王洪海
出处 《生物技术通讯》 CAS 2010年第1期107-111,共5页 Letters in Biotechnology
基金 国家"十一五"重大传染病专项(2008ZX10003005)
关键词 结核分枝杆菌 潜伏感染 诊断 Mycobacterium tuberculosis latent tuberculosis infection diagnosis
  • 相关文献

参考文献35

  • 1National Institute for Health and Clinical Excellence. Clin-ical Guideline 33, Tuberculosis: clinical diagnosis and management of tuberculosis and measurement for its prevention and control. NICE, London, UK, 2006. Available at: http:// www. nice.org.uk. Last accessed 1 December 2007.
  • 2Renata Z, Slavica D, Ivka Z. Interferon-3, and immunoglobulins in latent tuberculosis infection[J]. Arch Med Res, 2009,40:103- 108.
  • 3Jiang W M, Shao L Y, Zhang Y, et al. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-y/ release assay among HIV-infected individuals in BCGvaccinated area[J]. BMC Immunol, 2009,10:31.
  • 4Balcells M E, Perez C M, Chanqueo L, et al. A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile [C]. 45th Annual Meeting of the Infectious Diseases Society of America, 2008,12 (6):645-652.
  • 5Stephan C, Wolf T, Goetsch U, et ah Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country[J]. AIDS, 2008,22(18):2471-2479.
  • 6Aichelburg M C, Rieger A, Breitenecher F, et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-l-infected individuals [J]. Clin Infect Dis, 2009,48(7):954-962.
  • 7Bartalesi F, Vicidomini S, Goletti D, et al. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases[J]. Eur Respir J, 2009, 33(3):586-593.
  • 8Vassilopoulos D, Stamoulis N, Hadziyannis E, et al. Usefulness of enzyme-linked immunospot assay(Elispot) compared to tubereulin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor neerosis faetor treatment[J]. J Rheumatol, 2008,35(7):1271-1276.
  • 9Schoepfer A M, Flogerzi B, Fallegger S, et al. Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease[J]. Am J Gastroenterol, 2008,103(11):2799-2806.
  • 10Lee S S J, Chou K J, Su I J, et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON -TB GOLD, ELISPOT, and tuberculin skin test [J]. Clin Epidemiol Study, 2009,37:96-102.

同被引文献234

引证文献25

二级引证文献222

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部